Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)
Hong Kong · Delayed Price · Currency is HKD 1.360
+0.030 (2.26%)
Jul 28, 2025, 4:09 PM HKT
HKG:0460 Revenue
In the year 2024, Sihuan Pharmaceutical Holdings Group had annual revenue of 1.90B CNY with 2.18% growth. Sihuan Pharmaceutical Holdings Group had revenue of 951.41M in the half year ending December 31, 2024.
Revenue
1.90B CNY
Revenue Growth
+2.18%
P/S Ratio
6.14
Revenue / Employee
712.83K CNY
Employees
2,667
Market Cap
12.41B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.90B | 40.57M | 2.18% |
| Dec 31, 2023 | 1.86B | -320.65M | -14.70% |
| Dec 31, 2022 | 2.18B | -857.20M | -28.21% |
| Dec 31, 2021 | 3.04B | 574.17M | 23.30% |
| Dec 31, 2020 | 2.46B | -414.09M | -14.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 28.99B |